Cannabis and/or cannabinoid access and use by adults with cancer has outpaced the science supporting their clinical use. A newly-released guideline from the American Society of Clinical Oncology (ASCO) provides strategies for open, nonjudgmental communication between clinicians and adults with cancer about the use of cannabis and/or cannabinoids. The guideline was published in the Journal of Clinical Oncology.  Read the guideline here.